PLoS ONE (Jan 2022)

Fear of Covid 19 during the third wave of infection in Norwegian patients with type 1 diabetes.

  • Grethe Åstrøm Ueland,
  • Tony Ernes,
  • Tone Vonheim Madsen,
  • Eystein Sverre Husebye,
  • Sverre Sandberg,
  • Karianne Fjell Løvaas,
  • John Graham Cooper

DOI
https://doi.org/10.1371/journal.pone.0272133
Journal volume & issue
Vol. 17, no. 7
p. e0272133

Abstract

Read online

ObjectiveTo study the fear of Covid 19 infection among Norwegian patients with type 1 diabetes.Research design and methodsFear of Covid 19 scale, a validated scale assessing the fear of Covid 19, was sent electronically to 16255 patients with type 1 diabetes in May 2021. The items are rated on a scale from 1 to 5 (total scores from 7 to 35). The higher the score, the greater the fear.Results10145 patients, 52% of the Norwegian adult type 1 diabetes population, completed the questionnaire. The mean total fear score was 13.8 (SD 5.8). Women experienced more fear than men (OR 1.96), and fear increased significantly with increasing age for both genders (pConclusionAssessment of fear of Covid 19 in the type 1 diabetes population in Norway revealed an overall low fear during the third wave of infection. Patients considered to be at high risk of serious disease, such as older individuals, smokers and obese individuals expressed more fear than low risk individuals. The degree of fear was also associated with sex, ethnicity, educational/working status, glycemic control and presence of complications.